1. Adjuvant zoledronic acid reduces fractures in breast cancer patients; an AZURE (BIG 01/04) study. (May 2018) Authors: Wilson, C.; Bell, R.; Hinsley, S.; Marshall, H.; Brown, J.; Cameron, D.; Dodwell, D.; Coleman, R. Journal: European journal of cancer Issue: Volume 94(2018) Page Start: 70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effects of neoadjuvant chemotherapy with or without zoledronic acid on pathological response: A meta-analysis of randomised trials. (February 2016) Authors: Kroep, J.R.; Charehbili, A.; Coleman, R.E.; Aft, R.L.; Hasegawa, Y.; Winter, M.C.; Weilbaecher, K.; Akazawa, K.; Hinsley, S.; Putter, H.; Liefers, G.J.; Nortier, J.W.R.; Kohno, N. Journal: European journal of cancer Issue: Volume 54(2016) Page Start: 57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effects of neoadjuvant chemotherapy with or without zoledronic acid on pathological response: A meta-analysis of randomised trials. (February 2016) Authors: Kroep, J.R.; Charehbili, A.; Coleman, R.E.; Aft, R.L.; Hasegawa, Y.; Winter, M.C.; Weilbaecher, K.; Akazawa, K.; Hinsley, S.; Putter, H.; Liefers, G.J.; Nortier, J.W.R.; Kohno, N. Journal: European journal of cancer Issue: Volume 54(2016) Page Start: 57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Erratum to: The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection. Issue 1 (December 2016) Authors: Snee, M.; McParland, L.; Collinson, F.; Lowe, C.; Striha, A.; Baldwin, D.; Naidu, B.; Sebag-Montefiore, D.; Gregory, W.; Bestall, J.; Hewison, J.; Hinsley, S.; Franks, K. Journal: Pilot and feasibility studies Issue: Volume 2:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection. Issue 1 (December 2016) Authors: Snee, M.; McParland, L.; Collinson, F.; Lowe, C.; Striha, A.; Baldwin, D.; Naidu, B.; Sebag-Montefiore, D.; Gregory, W.; Bestall, J.; Hewison, J.; Hinsley, S.; Franks, K. Journal: Pilot and feasibility studies Issue: Volume 2:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection. Issue 1 (December 2016) Authors: Snee, M.; McParland, L.; Collinson, F.; Lowe, C.; Striha, A.; Baldwin, D.; Naidu, B.; Sebag-Montefiore, D.; Gregory, W.; Bestall, J.; Hewison, J.; Hinsley, S.; Franks, K. Journal: Pilot and feasibility studies Issue: Volume 2:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗